Concepedia

Author

Anna Fogdell‐Hahn

Karolinska InstitutetORCID

Also Known As

A Fogdell-Hahn, A. Fogdell-Hahn, A. Fogdell‐Hahn, A. Fogdell–Hahn, ANNA FOGDELL-HAHN, Anna Fogdell-Hahn, Anna Fogdell‐Hahn, Fogdell-Hahn, Fogdell-Hahn, A, Fogdell-Hahn, Anna

145

Publications

4.1K

Citations

35

H-Index

89

Concepts

All Affiliations

Karolinska InstitutetKarolinska University HospitalUniversity of GothenburgUmeå UniversityInnsbruck Medical University
AF

About

Anna Fogdell‐Hahn is an author at Karolinska Institutet specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

23

984

2

Allergy

5

5

191

3

Public Health

4

4

375

4

Social Sciences

1

1

13

5

Allergy Medicine

1

1

12

Anna Fogdell‐Hahn

×

74

Publications

3.8K

Citations

33

H-Index

YearCitations

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna, Peter Alping, Joachim Burman,

JAMA Neurology

2019

492

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

Anna Fogdell‐Hahn, Arturs Ligers, M. Grønning,

Tissue Antigens

2000

297

HLA-DR Predicts the Prognosis in Scandinavian Patients with Pulmonary Sarcoidosis

M Berlin, Anna Fogdell‐Hahn, Olle Olerup,

American Journal of Respiratory and Critical Care Medicine

1997

272

Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections

Donatella Donati, Nahid Akhyani, Anna Fogdell‐Hahn,

Neurology

2003

197

Association of Human Herpesvirus-6B with Mesial Temporal Lobe Epilepsy

Julie Fotheringham, Donatella Donati, Nahid Akhyani,

PLoS Medicine

2007

142

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Peter Alping, Johan Askling, Joachim Burman,

Annals of Neurology

2020

130

Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes

Jenny Ahlqvist, Julie Fotheringham, Nahid Akhyani,

Journal of NeuroVirology

2005

107

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

Carolina Holmén, Fredrik Piehl, Jan Hillert,

Multiple Sclerosis Journal

2011

104

Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies

Nicky Dunn, Alexander Juto, Malin Ryner,

Multiple Sclerosis Journal

2017

103

Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis

Elin Engdahl, Rasmus Gustafsson, Jesse Huang,

Frontiers in Immunology

2019

85

Page 1